CRO News
-
Bioanalytical Services | Breaking News | CRO News | R&D
TherapeutAix Expands R&D Network
Adds CROs Alderley Analytical and Peak Proteins to address Pharmacokinetics and Pharmacodynamics challenges for clients.Contract Pharma Staff 10.29.20
-
Breaking News | Clinical Trials | CRO News
BARDA Reselects ICON as Preferred Partner
Continues as part of BARDA’s exclusive Medical Countermeasures Clinical Studies NetworkContract Pharma Staff 10.29.20
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | CRO News | Industry News
Reaction Biology and 4HF Biotec Collaborate
Announce new cell-based service offering that combines their technologies.Contract Pharma Staff 10.21.20
-
Breaking News | Collaborations & Alliances | CRO News
BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services
Will support new medical countermeasure research in the fight against emerging infectious disease.Contract Pharma Staff 10.08.20
-
CRO News | Information Technology
PPD Achieves ISO Information Security Management Certification
Successfully completes audit process meeting international standards in ensuring the confidentiality, integrity and availability of customer data.Contract Pharma Staff 09.30.20
-
Bio News | Breaking News | CRO News | Industry News
Kymos and Prolytic Merge
Become Kymos Group, a pan-European CRO dedicated to innovative pharmaceuticals.Contract Pharma Staff 09.28.20
-
Breaking News | Clinical Trials | CRO News | Information Technology
Parexel Acquires Roam Analytics’ NLP Capability
Expands capabilities in Artificial Intelligence and Machine Learning to further streamline and extract insights from unstructured data.Contract Pharma Staff 09.23.20
-
Breaking News | CRO News
Europital Launches as Full Service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.Contract Pharma Staff 09.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | CRO News
DoD Selects Pharm-Olam to Support to Operation Warp Speed Vax Trials
To support Phase III clinical trials of one or more lead COVID-19 vaccine candidates being developed under Operation Warp Speed.Contract Pharma Staff 09.23.20
-
Clinical Trials | CRO News | Drug Development
PPD, Lupus Therapeutics to Support Lupus Clinical Research
To provide enhanced protocol and trial optimization capabilities for its customers leveraging LT’s scientific, operational and drug development expertise.Contract Pharma Staff 09.04.20
-
Breaking News | CRO News | Facilities
Europital Opens New Site in Oxford
Forecasts 30% CAGR over the next three years.Contract Pharma Staff 08.26.20
-
Breaking News | CRO News | Drug Discovery | Facilities | Industry News
Eurofins Expands Chemistry Capacity
Its new 63,000 square foot facility in Spain is nearing completion.Contract Pharma Staff 08.24.20
-
Breaking News | Clinical Trials | CRO News | Drug Development | Laboratory Testing
PPD, Pfizer Ink New Service Pact
PPD to provide drug development services to advance Pfizer’s portfolio under new three-year agreement.Contract Pharma Staff 08.03.20
-
Breaking News | Clinical Trials | CRO News
Covance Acquires GlobalCare
Expands decentralized clinical trials capabilities globally, enabling recruitment and increasing access to trials.Contract Pharma Staff 07.28.20
-
Breaking News | Clinical Trials | CRO News | Drug Development
Syneos Health, Pfizer Ink New Service Agreement
Three-year agreement to provide global product development services to support Pfizer's portfolio.Contract Pharma Staff 07.13.20
-
Analytical Services | Breaking News | Chemistry | CRO News | Industry News | R&D
Frontage Acquires ACME Bioscience
Expands synthetic and medicinal chemistry and process research and development services.Contract Pharma Staff 07.08.20
-
Clinical Trials | CRO News | Trials & Filings
Lipidor, Cadila Sign Agreement for Phase III Trial of AKP-02
Cadila Pharmaceuticals to conduct a Phase III study for Lipidor's anti-psoriasis candidate AKP-02.Contract Pharma Staff 07.07.20
-
Breaking News | Clinical Trials | CRO News | Drug Development
LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution
Offers integrated data collection, actionable views of critical study data, COVID-19 targeted risk management and recovery assessment.Contract Pharma Staff 06.29.20
-
Breaking News | CRO News
PPD Expands COVID-19 Lab Test Portfolio
Adds five new molecular, serology and functional assays designed expressly for COVID-19 vaccine and therapy development programs.Contract Pharma Staff 06.25.20
-
Analytical Services | Breaking News | CRO News | Drug Development | Industry News | Preclinical Outsourcing
Frontage Establishes Center of Excellence
Quantitative whole-body autoradiography CoE will be located in Exton, PA and headed by Michael Potchobia.Contract Pharma Staff 06.02.20
